HTFL (HeartFlow) DeferredTaxAndRevenue: $1.6 Mil (As of Mar. 2026)


HTFL HeartFlow Inc HTFL
12 GF Score
Price $29.33
! 4 Warning Signs
View Full Analysis

What is HeartFlow DeferredTaxAndRevenue?

HeartFlow HTFL -15.83% 12 DeferredTaxAndRevenue is $1.6 Mil as of Mar. 2026. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

HeartFlow's current deferred tax and revenue for the quarter that ended in Mar. 2026 was $1.6 Mil.

HeartFlow DeferredTaxAndRevenue Related Terms

HeartFlow DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for HeartFlow's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartFlow DeferredTaxAndRevenue Chart

HeartFlow Annual Data
Trend Dec23 Dec24 Dec25
DeferredTaxAndRevenue
2.11 1.04 0.63

HeartFlow Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.42 0.42 0.52 0.63 1.58
HTFL
12GF Score
HeartFlow Inc HTFL
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $1.6 Mil mean?
HeartFlow (HTFL) has a DeferredTaxAndRevenue of $1.6 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on HeartFlow.
Is HeartFlow's DeferredTaxAndRevenue too high?
HeartFlow's current DeferredTaxAndRevenue is $1.6 Mil. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's DeferredTaxAndRevenue compare to PRVA and WAY?
HeartFlow's DeferredTaxAndRevenue of $1.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on HeartFlow. HeartFlow's current DeferredTaxAndRevenue is $1.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current DeferredTaxAndRevenue of $1.6 Mil. The current DeferredTaxAndRevenue is $1.6 Mil. HeartFlow's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For HeartFlow (HTFL), the current DeferredTaxAndRevenue is $1.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeartFlow Business Description

Address 331 East Evelyn Avenue, Mountain View, CA, USA, 94041
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score

Get the complete analysis for HTFL

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.33
Price